Key result
Pulmonary vasodilators improve Eisenmenger syndrome survival and quality of life, limiting transplantation to select cases.
Why the study?
The optimal transplantation strategy for adult Eisenmenger syndrome remains debated, particularly given the benefits of pulmonary vasodilator therapy and resource limitations.
What are the optimal therapeutic options, including medical therapy and transplantation, for adult patients with Eisenmenger syndrome?
What are the optimal therapeutic options, including medical therapy and transplantation, for adult patients with Eisenmenger syndrome?
Pulmonary vasodilator therapy has improved survival and quality of life in adult Eisenmenger syndrome, making optimal medical therapy a viable long-term option and reserving transplantation for carefully selected cases based on specific anatomical defects.
Answers are grounded in this paper and cite their sources.
May support vasodilator-first strategy in Eisenmenger syndrome; leaves open prospective validation of transplantation criteria.
Patients of Eisenmenger syndrome are a heterogeneous group of subjects with varying underlying cardiac defects, longevity, and quality of life. The optimal transplantation strategy, ie, single lung, bilateral lung with intra-cardiac repair, or combined heart-lung transplantation remains a matter of debate, requiring careful consideration of the specific cardiac defect, age at presentation, ventricular function, organ availability, and resources available at the treating centre. The introduction of pulmonary vasodilator therapy has improved the survival curves and led to better quality of life even without transplantation. This review aims to discuss the merits, demerits, optimal timing, and type of transplantation options for adult patients with ES, particularly in countries with resource limitations such as ours (India).
No takes yet. Share an insight, caveat, or question.
I Sathyamurthy (2025) conducted a review in Eisenmenger syndrome. Transplantation and pulmonary vasodilators was evaluated. In adult patients with Eisenmenger syndrome, pulmonary vasodilator therapy has improved survival and quality of life, suggesting that transplantation should be reserved for carefully selected cases.
Synapse has enriched 10 related papers. Consider them for comparative context: